Literature DB >> 14641797

Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis.

K Katchar1, A Eklund, J Grunewald.   

Abstract

OBJECTIVES: The balance between Th1 and Th2 T cells, classified by virtue of their cytokine production can in an immune response influence the phenotype and progression of several clinical diseases. In this study, we examined the expression of Th1 associated chemokine and cytokine receptors CXCR3, CCR5, and interleukin (IL)-12R, IL-18R, respectively, as well as of the Th2 associated chemokine receptors CCR4 and CXCR4 on CD4+ and CD8+ T cells.
SUBJECTS: Eighteen patients with untreated pulmonary sarcoidosis.
MATERIALS AND METHODS: We used monoclonal antibodies and flow cytometry to analyse the expression of chemokine receptors CXCR3, CXCR4, CCR4 CCR5 and cytokine receptors IL-12R, IL-18R in combination with anti-CD4 and anti-CD8 mAbs in bronchoalveolar lavage fluid (BAL) and peripheral blood lymphocytes (PBL) from sarcoidosis patients.
RESULTS: There were significantly more BAL CD4+ T cells expressing CXCR3, CCR5, IL-12R and IL-18R compared with paired PBL CD4+ T cells. In contrast, the Th2 associated chemokine receptors CXCR4 and CCR4 were expressed by a fewer percentage of BAL CD4+ compared with PBL CD4+ T cells. There was a positive correlation between the percentage of BAL lymphocytes and the number of CXCR3 and CCR5 expressing CD4+ BAL T cells. Also, the number of CD4+ IL-18R+ BAL fluid cells correlated negatively with disease duration.
CONCLUSIONS: The lung accumulation of CXCR3, CCR5, IL-12R and IL-18R expressing T cells is in line with previous reports showing elevated levels in the lung of the corresponding ligands in sarcodosis. Blocking such ligands and/or receptors may develop into a future immunomodulatory therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641797     DOI: 10.1111/j.1365-2796.2003.01230.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  17 in total

1.  Requirement for chemokine receptor 5 in the development of allergen-induced airway hyperresponsiveness and inflammation.

Authors:  Yasuko Fuchimoto; Arihiko Kanehiro; Nobuaki Miyahara; Hikari Koga; Genyo Ikeda; Koichi Waseda; Yasushi Tanimoto; Satoshi Ueha; Mikio Kataoka; Erwin W Gelfand; Mitsune Tanimoto
Journal:  Am J Respir Cell Mol Biol       Date:  2011-07-14       Impact factor: 6.914

2.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema.

Authors:  Bing Ma; Min-Jong Kang; Chun Geun Lee; Svetlana Chapoval; Wei Liu; Qingsheng Chen; Anthony J Coyle; José M Lora; Dominic Picarella; Robert J Homer; Jack A Elias
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808

Review 4.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

5.  Differing distributions of CXCR3- and CCR4-positive cells among types of interstitial pneumonia associated with collagen vascular diseases.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Takashi Niimi; Yuji Ohtsuki; Jiro Fujita; Hiroyoshi Maeda; Shigeki Sato; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2006-11-24       Impact factor: 4.064

6.  Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study.

Authors:  Katerina M Antoniou; Giannoula Soufla; Athanasia Proklou; George Margaritopoulos; Christiana Choulaki; Rena Lymbouridou; Katerina D Samara; Demetrios A Spandidos; Nikolaos M Siafakas
Journal:  Clin Dev Immunol       Date:  2010-02-14

7.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02

8.  CC chemokine receptor 5 gene polymorphisms in beryllium disease.

Authors:  H Sato; L Silveira; P Spagnolo; M Gillespie; E B Gottschall; K I Welsh; R M du Bois; L S Newman; L A Maier
Journal:  Eur Respir J       Date:  2010-01-14       Impact factor: 16.671

9.  CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.

Authors:  Y Nishioka; K Manabe; J Kishi; W Wang; M Inayama; M Azuma; S Sone
Journal:  Clin Exp Immunol       Date:  2007-06-05       Impact factor: 4.330

10.  Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome.

Authors:  Annegret Fischer; Ruta Valentonyte; Almut Nebel; Michael Nothnagel; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  J Mol Med (Berl)       Date:  2008-03-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.